Cargando…

Myeloid malignancies‐related somatic mutations in aging individuals

We search for the presence of somatic mutations in 12 genes related to MDS, MPN, and AML in a Brazilian cohort composed of 609 elderly individuals from a census‐based sample.[Image: see text]

Detalles Bibliográficos
Autores principales:	Coutinho, Diego F., Zalcberg, Ilana R., Monte‐Mór, Bárbara C. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6565578/ https://www.ncbi.nlm.nih.gov/pubmed/31006989 http://dx.doi.org/10.1002/mgg3.683

Ejemplares similares

Is the BCR-ABL/GUSB transcript level at diagnosis an early predictive marker for chronic myeloid leukemia patients treated with imatinib?
por: Bonecker, Simone, et al.
Publicado: (2015)

Genetic Alterations in Essential Thrombocythemia Progression to Acute Myeloid Leukemia: A Case Series and Review of the Literature
por: Ayres-Silva, Jackline P., et al.
Publicado: (2018)

Myeloid Neoplasias: What Molecular Analyses Are Telling Us
por: Gutiyama, Luciana M., et al.
Publicado: (2012)

Acquired somatic variants in inherited myeloid malignancies
por: Armes, Hannah, et al.
Publicado: (2022)

Somatic SETBP1 mutations in myeloid malignancies
por: Makishima, Hideki, et al.
Publicado: (2013)

Activating somatic and germline TERT promoter variants in myeloid malignancies
por: Nofrini, Valeria, et al.
Publicado: (2020)

Preexisting TP53 mutation in therapy-related acute myeloid leukemia
por: Schulz, Eduard, et al.
Publicado: (2014)

Somatic Mutations in Breast Cancer: The Tip of the Iceberg
por: Park, Jung Ho, et al.
Publicado: (2022)

Somatic mutations are present in all members of the AKT family in endometrial carcinoma
por: Dutt, A, et al.
Publicado: (2009)

Somatic mutations may contribute to asymmetry in neurodegenerative disorders
por: Proukakis, Christos
Publicado: (2022)

Bone marrow stroma cells derived from mononuclear cells at diagnosis as a source of germline control DNA for determination of somatic mutations in acute myeloid leukemia
por: Mujahed, H, et al.
Publicado: (2017)

New somatic BRAF splicing mutation in Langerhans cell histiocytosis
por: Héritier, Sébastien, et al.
Publicado: (2017)

Detection of somatic TP53 mutations and 17p deletions in patients with chronic lymphocytic leukemia: a review of the current methods
por: Chauffaille, Maria de Lourdes L.F., et al.
Publicado: (2020)

A novel machine learning approach (svmSomatic) to distinguish somatic and germline mutations using next-generation sequencing data
por: Mao, Yu-Fang, et al.
Publicado: (2021)

Somatic mutations of calreticulin in a Brazilian cohort of patients with myeloproliferative neoplasms
por: Machado-Neto, João Agostinho, et al.
Publicado: (2015)

PATH-30. EXOSOMES AS A SOURCE OF PLASMA ctDNA TO IDENTIFY POINT MUTATIONS IN PEDIATRIC GLIOMA PATIENTS
por: Nobre, Liana, et al.
Publicado: (2020)

The mutational landscape of atypical chronic myeloid leukemia
por: Langabeer, Stephen E.
Publicado: (2019)

Reply: Somatic mutations are present in all members of the AKT family in endometrial carcinoma
por: Shoji, K, et al.
Publicado: (2009)

Identification of Somatic KRAS Mutation in a Korean Baby with Nevus Sebaceus Syndrome
por: Kim, Sung Woo, et al.
Publicado: (2015)

Sex-related differences in death control of somatic cells
por: Giampietri, Claudia, et al.
Publicado: (2013)

Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia
por: Sun, Jiewen, et al.
Publicado: (2020)

Somatic Mutations of TP53 and Prognostic Factors for Primary Operable Breast Cancer: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Pathogenic/Likely Pathogenic Somatic CDK12 Mutations in Black Men With Prostate Cancer
por: Sartor, Oliver, et al.
Publicado: (2023)

ABO Blood Group Antigen Changes in Acute Myeloid Leukemia and No Significant Association With RUNX1 and GATA2 Somatic Variants
por: Jeong, In Hwa, et al.
Publicado: (2023)

Expression of CEBPA is reduced in RUNX1-mutated acute myeloid leukemia
por: Grossmann, V, et al.
Publicado: (2012)

Allelic imbalance in CALR somatic mutagenesis
por: Harutyunyan, A S, et al.
Publicado: (2015)

Imatinib resistance: a review of alternative inhibitors in chronic myeloid leukemia
por: Bitencourt, Roberta, et al.
Publicado: (2011)

Concurrent chronic myeloid leukemia and CALR-mutated myeloproliferative neoplasm
por: Langabeer, Stephen E.
Publicado: (2020)

Somatic CLL mutations occur at multiple distinct hematopoietic maturation stages: documentation and cautionary note regarding cell fraction purity
por: Marsilio, S, et al.
Publicado: (2018)

Flt3-ITD mutations in a mouse model of radiation-induced acute myeloid leukaemia
por: Finnon, R, et al.
Publicado: (2012)

Identification of GSX2 and AF10 as NUP98 partner genes in myeloid malignancies
por: Soler, G, et al.
Publicado: (2013)

Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups
por: Riva, L, et al.
Publicado: (2013)

Prevalence of somatic mutations in patients with aplastic anemia using peripheral blood cfDNA as compared with BM
por: Albitar, A, et al.
Publicado: (2018)

NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors
por: Byrgazov, K, et al.
Publicado: (2017)

Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk
por: Haring, Bernhard, et al.
Publicado: (2022)

The specific distribution pattern of IKZF1 mutation in acute myeloid leukemia
por: Zhang, Xiang, et al.
Publicado: (2020)

Not BCL2 mutation but dominant mutation conversation contributed to acquired venetoclax resistance in acute myeloid leukemia
por: Zhang, Xiang, et al.
Publicado: (2021)

The prognostic significance of trisomy 4 in acute myeloid leukaemia is dependent on age and additional abnormalities
por: Chilton, L, et al.
Publicado: (2016)

Chronic myeloid leukemia as a secondary malignancy after diffuse large B-cell lymphoma
por: Lee, Ha-young, et al.
Publicado: (2014)

Somatic mutations in homologous recombination pathway predict favourable prognosis after immunotherapy across multiple cancer types
por: Liu, Zaoqu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i39mdvolek3q1p868dv1k4qd04